DHX9-IN-2
CAS No. 2973395-71-8
DHX9-IN-2( —— )
Catalog No. M37315 CAS No. 2973395-71-8
DHX9-IN-2 is an inhibitor targeting ATP-dependent RNA de-helicase A (DHX9) with anticancer and antitumor activity for cancer research.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 265 | In Stock |
|
| 5MG | 242 | In Stock |
|
| 10MG | 376 | In Stock |
|
| 25MG | 539 | In Stock |
|
| 50MG | 685 | In Stock |
|
| 100MG | 886 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDHX9-IN-2
-
NoteResearch use only, not for human use.
-
Brief DescriptionDHX9-IN-2 is an inhibitor targeting ATP-dependent RNA de-helicase A (DHX9) with anticancer and antitumor activity for cancer research.
-
DescriptionDHX9-IN-2 (example 31)is an inhibitor of ATP-dependent RNA helicase A (DHX9), with the IC50 of 0.0698 nM that has antitumor activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetDNA/RNA Synthesis
-
RecptorDNA/RNA Synthesis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2973395-71-8
-
Formula Weight421.92
-
Molecular FormulaC18H16ClN3O3S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (237.01 mM; Ultrasonic )
-
SMILESO=C(NC1=CC(Cl)=CC(=C1)NS(=O)(=O)C)C=2SC=C(C2)C=3N=CC=CC3C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. DANIELS Matthew H., et al. Preparation of imidazopyridines, thienopyrimidines, pyrrolopyrimidines and related heterocycles as inhibitors of RNA helicase DHX9 useful in treatment of cancers. World Intellectual Property Organization, WO2023154519 A1 2023-08-17
molnova catalog
related products
-
2-O-(2-Methoxyethyl)...
2'-O-(2-Methoxyethyl)adenosine is a nucleoside analog used to improve RNA target affinity and nuclease resistance of therapeutic oligonucleotides in preclin.
-
Osalmid
Osalmid is a choleretic drug.
-
Sarmustine
Sarmustine (SarCNU) is an alkylating agent with anticancer activity that inhibits the growth of prostate cancer cells via p53-dependent and p53-independent pathways.
Cart
sales@molnova.com